final overall survival results from the phase 3 solo2 trial for ovarian cancer
Published 4 years ago • 1K plays • Length 25:59Download video MP4
Download video MP3
Similar videos
-
2:23
dr. poveda on the results of the solo2 trial in ovarian cancer
-
5:06
dana chase, md, facog, on interpretations of the overall survival results of the phase 3 solo2 study
-
5:09
robert coleman, md, describes the overall survival outcomes of the phase 3 solo2 clinical study
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
1:13
updated overall survival findings from the phase iii intrigue trial
-
2:20
dr. markman on overall survival as an endpoint in ovarian cancer trials
-
1:02:57
peri-operative therapy in urothelial carcinoma: uromigos live 2024
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
7:38
results from phiii solo1 trial in brcam ovarian cancer
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
26:02
updates in ovarian cancer: frontline maintenance
-
6:15
the gog-0213 trial in recurrent ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
2:10
asco: final overall survival results for olaparib maintenance in brca-mutated ovarian cancer
-
1:42
final ananova2 survival data support niraparib plus bevacizumab in recurrent ovarian cancer
-
2:09
dr. moore on the nova trial for ovarian cancer
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib